Filing Details
- Accession Number:
- 0001062993-22-019850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-22 11:46:51
- Reporting Period:
- 2022-09-20
- Accepted Time:
- 2022-09-22 11:46:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1799011 | Lucid Diagnostics Inc. | LUCD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678195 | Stanley Lapidus | One Grand Central Place, Suite 4600 New York NY 10165 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-20 | 17,000 | $1.71 | 152,320 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-09-20 | 16,864 | $1.70 | 135,456 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.